Behaviour of small solutes and large drugs in a lipid bilayer from computer simulations.
To reach their biological target, drugs have to cross cell membranes, and understanding passive membrane permeation is therefore crucial for rational drug design. Molecular dynamics simulations offer a powerful way of studying permeation at the single molecule level. Starting from a computer model proven to be able to reproduce the physical properties of a biological membrane, the behaviour of small solutes and large drugs in a lipid bilayer has been studied. Analysis of dihedral angles shows that a few nano seconds are sufficient for the simulations to converge towards common values for those angles, even if the starting structures belong to different conformations. Results clearly show that, despite their difference in size, small solutes and large drugs tend to lie parallel to the bilayer normal and that, when moving from water solution into biomembranes, permeants lose degrees of freedom. This explains the experimental observation that partitioning and permeation are highly affected by entropic effects and are size-dependent. Tilted orientations, however, occur when they make possible the formation of hydrogen bonds. This helps to understand the reason why hydrogen bonding possibilities are an important parameter in cruder approaches which predict drug absorption after administration. Interestingly, hydration is found to occur even in the membrane core, which is usually considered an almost hydrophobic region. Simulations suggest the possibility for highly polar compounds like acetic acid to cross biological membranes while hydrated. These simulations prove useful for drug design in rationalising experimental observations and predicting solute behaviour in biomembranes.
Bemporad
D
D
School of Chemistry, University of Southampton, Highfield, Southampton, SO17 1BJ, UK.
Luttmann
C
C
Essex
J W
JW
D000319:Adrenergic beta-Antagonists / Q000737:chemistry* / Q000493:pharmacokinetics*; D002463:Cell Membrane Permeability; D003198:Computer Simulation; D004337:Drug Carriers / Q000737:chemistry; D015195:Drug Design; D006860:Hydrogen Bonding; D008051:Lipid Bilayers / Q000378:metabolism*; D012996:Solutions
D000319:Adrenergic beta-Antagonists; D004337:Drug Carriers; D008051:Lipid Bilayers; D012996:Solutions